Skip to main content
Clinical Trials/NCT06879535
NCT06879535Active, not recruitingNot Applicable

ESTUDIO DE APLICACIÓN DE ESCALAS PARA VALORACIÓN SINTOMÁTICA DEL SÍNDROME DE COVID PERSISTENTE

Hospital del Rio Hortega1 site in 1 country80 target enrollmentStarted: March 28, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
80
Locations
1
Primary Endpoint
Fatigue

Study Overview

Brief Summary

The goal of this observational study is to learn about the long-term evolution of long COVID.

The main question it aims to answer is:

Does the main symptoms of the patients diagnosed with long COVID aproximate to those of patients who have had COVID acute infection without devoloping long COVID? Participants will answer mailed survey questions about their main symptons.

Detailed Description

Scales, indexes and questionnaires were mailed to 40 patients with long COVID to evaluate their main symptoms. Fatigue, emotional disorders, sleep disorders, cognitive impairments, dyspnea, physical activity, quality of life and pain were analyzed. The patients were reassessed after three years. The same scales, indexes and questionnaires were also sent to a control group of 40 volunteers of the same age and sex as the cases.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •patients older than 18 years old and younger than 75 years old
  • •patients who accepted to participate in the study
  • •patients who have had COVID acute infection
  • •patients who have long COVID (cases)

Exclusion Criteria

  • •patients who refused to participate in the study at any time of the study
  • •patients whose diagnosis of long COVID was revoked during the study (cases)

Outcomes

Primary Outcomes

Fatigue

Time Frame: From enrollment to three years later

MFIS scale

Emotional disorders

Time Frame: From enrollment to three years later

HADS scale

Sleep disorders

Time Frame: From enrollment to three years later

PSQI

Cognitive impairments

Time Frame: From enrollment to three years later

MFE-30

Dyspnea

Time Frame: From enrollment to three years later

mMRC

Physical activity

Time Frame: From enrollment to three years later

GPAQ

Quality of life (healthcare)

Time Frame: From enrollment to three years later

SF-36

Pain (healthcare)

Time Frame: From enrollment to three years later

EGDC

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Hospital del Rio Hortega
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Andrés Carrascosa Gil

Médico Licenciado Especialista en Anestesiología y Reanimación

Hospital del Rio Hortega

Study Sites (1)

Loading locations...

Similar Trials